Skip to main content
Equibles

Alyeska Investment Group, L.P.

Position in INBS — Intelligent Bio Solutions Inc.

CIK 1453072 CHICAGO, IL
Back to INBS Full portfolio

Position in INBS

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$126,962
-$559,999 QoQ
Shares Held
37,956
-43.6% QoQ
Ownership
1.25%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2024
7 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in INBS Over Time

Shares Held

Position Value (USD)

Derivatives in INBS

reported options exposure · as of Jun 30, 2024
CallValue
$427,987
CallShares
22,291
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Medical Devices

Healthcare · as of Jun 30, 2026

Alyeska Investment Group, L.P. holds $334,591,356 across 9 Medical Devices names.

# Ticker Company Shares Value (USD) Open
1 ABT
Abbott Laboratories
 1,176,080 $106,717,499
2 BRKR
Bruker Corp
 1,410,164 $84,863,669
3 EW
Edwards Lifesciences Corp
 812,860 $73,531,315
4 SYK
Stryker Corp
 167,524 $52,743,256
5 LUCD
Lucid Diagnostics Inc.
 8,856,844 $9,476,823
6 ALMR
Alamar Biosciences, Inc.
 113,396 $3,071,897
7 QTI
Qt Imaging Holdings, Inc.
 702,776 $2,860,298
8 ADGM
Adagio Medical Holdings, Inc.
 1,159,615 $756,068

All Filings in INBS

Export CSV
8 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $126,962 37,956
2025-09-30 $686,961 673,492
2025-06-30 $1,055,894 613,892
2025-03-31 $884,004 613,892
2024-09-30 $356,724 206,199
2024-06-30 $427,987 222,910
2024-03-31 $940,680 222,910
2024-03-31 $870,159 206,199